Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

NCT01785186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

DRUG: SQ109
DRUG: Rifampicin
DRUG: Moxifloxacin
DRUG: isoniazid
DRUG: pyrazinamide
DRUG: ethambutol
DIETARY_SUPPLEMENT: pyridoxine

Sponsor

Michael Hoelscher

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]